TORTINI

For your delectation and delight, desultory dicta on the law of delicts.

Unreported Decisions on Expert Witness Opinion in New Jersey

February 21st, 2012

In New Jersey, as in other states, unpublished opinions have a quasi-outlaw existence.  According to the New Jersey Rules of Court, unpublished opinions are not precedential.  By court fiat, the court system has declared that it can act a certain way in a given case, and not have to follow its own lead in other cases:

No unpublished opinion shall constitute precedent or be binding upon any court. Except for appellate opinions not approved for publication that have been reported in an authorized administrative law reporter, and except to the extent required by res judicata, collateral estoppel, the single controversy doctrine or any other similar principle of law, no unpublished opinion shall be cited by any court. No unpublished opinion shall be cited to any court by counsel unless the court and all other parties are served with a copy of the opinion and of all contrary unpublished opinions known to counsel.

New Jersey Rule of Court 1:36-3 (Unpublished Opinions).

Litigants down the road may feel that they are not being given the equal protection of the law, but never mind.  Res judicata and collateral estoppel are in, but stare decisis is out.  Consistency and coherence are so difficult, surely it is better to be free from having from these criteria of rationality unless we decide to “opt in” by publishing opinions with our decisions.  As many other scholars and commentators have noted, rules of this sort allow decisions from other states, and even other countries, to be potentially persuasive, whereas by court rule and fiat, an unpublished decision of the deciding court can not have any precedential value.  Why then permit unpublished cases to be cited at all?

Having tracked decisions, published and un-, in New Jersey for many years, I am left with an impression that the Appellate Division has a tendency to refuse to publish opinions of decisions in which it has reversed the trial court’s refusal to exclude expert witness testimony, or in which it has affirmed the trial court’s exclusion of expert testimony.  Opinions that explain the affirmance of a denial of expert witness exclusion or the reversal of a trial court’s grant of exclusion appear to be published more often.  Stated as a four-fold table:

  Trial Court Permits Expert Trial Court Bars Expert
Appellate Court Affirms Published Not Published
Appellate Court Reverses Not Published Publish

My impression is that there is an institutional bias against creating a body of law that illuminates the criteria for admission and for exclusion of expert witness opinion testimony. This is only an impression, and I do not have statistics, descriptive or inferential on these judicial behaviors.  From a jurisprudential perspective, the affirmance of an exclusion below, or the reversal of a denial of exclusion below, should be at least as important as publishing the reversal of an exclusion below.  The goal of announcing to the Bar and to trial judges the criteria for inclusion and exclusion would seem to suggest greater publication of the opinions, from the two unpublished cells, in the contingency table, above.

No citation and no precedent rules are deeply problematic, and have attracted a great deal of scholarly attention.  See Erica Weisgerber, “Unpublished Opinions: A Convenient Means to an Unconstitutional End,” 97 Georgetown L.J. 621 (2009);  Rafi Moghadam, “Judge Nullification: A Perception of Unpublished Opinions,” 62 Hastings L.J. 1397 (2011);  Norman R. Williams, “The failings of Originalism:  The Federal Courts and the Power of Precedent,” 37 U.C.. Davis L. Rev. 761 (2004);  Dione C. Greene, “The Federal Courts of Appeals, Unpublished Decisions, and the ‘No-Citation Rule,” 81 Indiana L.J. 1503 (2006);  Vincent M. Cox, “Freeing Unpublished Opinions from Exile: Going Beyond the Citation Permitted by Proposed Federal Rule of Appellate Procedure 32.1,” 44 Washburn L.J. 105 (2004);  Sarah E. Ricks, “The Perils of Unpublished Non-Precedential Federal Appellate Opinions: A Case Study of The Substantive Due Process State-Created Danger Doctrine in One Circuit,” 81 Wash. L.Rev. 217 (2006);  Michael J. Woodruff, “State Supreme Court Opinion Publication in the Context of Ideology and Electoral Incentives.” New York University Department of Politics (March 2011);   Michael B. W. Sinclair, “Anastasoff versus Hart: The Constitutionality and Wisdom of Denying Precedential Authority to Circuit Court Decisions.”  See generally The Committee for the Rule of Law (website) (collecting scholarship and news on the issue of unpublished and supposedly non-precedential opinions).

What would be useful is an empirical analysis of the New Jersey Appellate Division’s judicial behavior in deciding whether or not to publish decisions for each of the four cells, in the four-fold table, above.  If my impression is correct, the suggestion of institutional bias would give further support to the abandonment of N.J. Rule of Court 1:36-3.

Interstitial Doubts About the Matrixx

February 6th, 2012

Statistics professors are excited that the United States Supreme Court issued an opinion that ostensibly addressed statistical significance.  One such example of the excitement is an article, in press, by Joseph B. Kadane, Professor in the Department of Statistics, in Carnegie Mellon University, Pittsburgh, Pennsylvania.  See Joseph B. Kadane, “Matrixx v. Siracusano: what do courts mean by ‘statistical significance’?” 11[x] Law, Probability and Risk 1 (2011).

Professor Kadane makes the sensible point that the allegations of adverse events did not admit of an analysis that would imply statistical significance or its absence.  Id. at 5.  See Schachtman, “The Matrixx – A Comedy of Errors” (April 6, 2011)”;  David Kaye, ” Trapped in the Matrixx: The U.S. Supreme Court and the Need for Statistical Significance,” BNA Product Safety and Liability Reporter 1007 (Sept. 12, 2011).  Unfortunately, the excitement has obscured Professor Kadane’s interpretation of the Court’s holding, and has led him astray in assessing the importance of the case.

In the opening paragraph of his paper, Professor Kadane quotes from the Supreme Court’s opinion that “the premise that statistical significance is the only reliable indication of causation … is flawed,” Matrixx Initiatives, Inc. v. Siracusano, ___ U.S. ___, 131 S.Ct. 1309 (2011).  The quote is accurate, but Professor Kadane proceeds to claim that this quote represents the holding of the Court. Kadane, supra at 1. The Court held no such thing.

Matrixx was a security fraud class action suit, brought by investors who claimed that the company misled them when they spoke to the market about the strong growth prospects of the company’s product, Zicam cold remedy, when they had information that raised concerns that might affect the product’s economic viability and its FDA license.  The only causation required for the plaintiffs to show was an economic loss caused by management’s intentional withholding of “material” information that should have been disclosed under all the facts and circumstances.  Plaintiffs do not have to prove that the medication causes the harm alleged in personal injury actions.  Indeed, it might turn out to be indisputable that the medication does not cause the alleged harm, but earlier, suggestive studies would provoke regulatory intervention and even a regulatory decision to withdraw the product from the market.  Investors obviously could be hurt under this scenario as much as, if not more than, if the medication caused the harms alleged by personal-injury plaintiffs. 

Kadane’s assessment goes awry in suggesting that the Supreme Court issued a holding about facts that were neither proven nor necessary for it to reach its decision.  Court can, and do, comment, note, and opine about many unnecessary facts or allegations in reaching a holding, but these statements are obiter dicta, if they are not necessary to the disposition of the case. Because medical causation was not required for the Supreme Court to reach its decision, its presence or absence was not, and could not, be part of the Court’s holding. 

Kadane makes a similar erroneous statement that the lower appellate courts, which earlier had addressed “statistical significance,” properly or improperly understood, found that “statistical significance in the strict sense [was] neither necessary … nor sufficient … to require action to remove a drug from the market.”  Id. at 6.  The earlier appellate decisions addressed securities fraud, however, not regulatory action of withdrawal of a product.  Kadane’s statement mistakes what was at issue, and what was decided, in all the cases discussed.

Kadane seems at least implicitly to recognize that medical causation is not at issue when he states that “the FDA does not require proof of causation but rather reasonable evidence of an association before a warning is issued.”  Id. at 7 (internal citation omitted).  All that had to have happened for the investors to have been harmed by the Company’s misleading statements was for Matrixx Initiatives to boast about future sales, and to claim that there were no health issues that would lead to regulatory intervention, when they had information raising doubts about their claim of no health issues. See FDA Regulations, 21 U.S.C. § 355(d), (e)(requiring drug sponsor to show adequate testing, labeling, safety, and efficacy); see also 21 C.F.R. § 201.57(e) (requiring warnings in labeling “as there is reasonable evidence of an association of a serious hazard with a drug; a causal relationship need not have been proved.”); 21 C.F.R. § 803.3 (adverse event reports address events possibly related to the drug or the device); 21 C.F.R. § 803.16 (adverse event report is not an admission of causation).

Kadane’s analysis of the case goes further astray when he suggests that the facts were strong enough for the case to have survived summary judgment.  Id. at 9.  The Matrixx case was a decision on the adequacy of the pleadings, not of the adequacy of the facts proven.  Elsewhere, Kadane acknowledges the difference between a challenge to the pleadings and the legal sufficiency of the facts, id. at 7 & n.8, but Kadane asserts, without explanation, that the difference is “technical” and does not matter.”  Not true.  The motion to dismiss is made upon receipt of the plaintiffs’ complaint, but the motion for summary judgment is typically made at the close of discovery, on the eve of trial.  The allegations can be conclusory, and they need have only plausible support in other alleged facts to survive a motion to dismiss.  The case, however, must have evidence of all material facts, as well as expert witness opinion that survives judicial scrutiny for scientific validity under Rule 702, to survive a motion for summary judgment, which comes much later in the natural course of any litigated case.

Kadane appears to try to support the conflation of dismissals on the pleadings and summary judgments by offering a definition of summary judgment that is not quite accurate, and potentially misleading:  “The idea behind summary judgment is that, even if every fact alleged by the opposing party were found to be true, the case would still fail for legal reasons.” Id. at 2.  The problem is that at the summary judgment stage, as opposed to the pleading stage, the party with the burden of proof cannot rest upon his allegations, but must come forward with facts, not allegations, to support every essential element of his case.  A plaintiff in a personal injury action (not a securities fraud case), for example, may easily survive a motion to dismiss by alleging medical causal connection, but at the summary judgment stage, that plaintiff must serve a report of an appropriately qualified expert witness, who in turn has presented a supporting opinion, reliably ground in science, to survive both evidentiary challenges and a dispositive motion.

Kadane concludes that the Matrixx decision’s “fact-based consideration” is consistent with a “Bayesian decision-theoretic approach that models how to make rational decisions under uncertainty.”  Id. at 9.  I am 99.99999% certain that Justice Sotomayor would not have a clue about what Professor Kadane was saying.  Although statistical significance may have played no role in the Court’s holding, and in Kadane’s Bayesian decision-theoretic approach, I am 100% certain that the irrelevance of statistical significance to the Court’s and Prof. Kadane’s approaches is purely coincidental.

Discovery into the Origin of Historian Expert Witnesses’ Opinions

January 30th, 2012

As every trial lawyer in America knows, the Federal Rules of Civil Procedure were recently changed to protect expert witness draft reports and lawyer-expert witness communications from discovery.  See Rule 26. Duty to Disclose; General Provisions Governing Discovery (amended effective December 2010).

In particular, Rule 26(b) (4)(B), and (C) provides:

(4)(B) Trial-Preparation Protection for Draft Reports or Disclosures. Rules 26(b)(3)(A) and (B) protect drafts of any report or disclosure required under Rule 26(a)(2), regardless of the form in which the draft is recorded.

(C) Trial-Preparation Protection for Communications Between a Party’s Attorney and Expert Witnesses. Rules 26(b)(3)(A) and (B) protect communications between the party’s attorney and any witness required to provide a report under Rule 26(a)(2)(B), regardless of the form of the communications, except to the extent that the communications:

(i) relate to compensation for the expert’s study or testimony;

(ii) identify facts or data that the party’s attorney provided and that the expert considered in forming the opinions to be expressed; or

(iii) identify assumptions that the party’s attorney provided and that the expert relied on in forming the opinions to be expressed.

In some ways, this amendment was a retrograde step.  Although protecting drafts and communications from discovery helps ease the expense and inconvenience of working with expert witnesses, the amendment also serves to protect unscrupulous lawyers and expert witnesses who work in concert to present tendentious opinions.

In the sciences, tendentious opinions will ultimately be embarrassed by future facts, but in the field of history, the interpretative narratives are often unfalsifiable and malleable.  Discovery into the creative process of historian expert witnesses’ opinions needs to be complete and thorough.

Consider the consider the case of Barry Castleman, who has testified for decades for the asbestos litigation industry, on historical issues in asbestos personal injury cases.  Back in 1986, when Castleman was still “researching” his opinions, he received a letter from plaintiffs’ lawyer, Tom Hart:

 

Mr. Barry Castleman                                                                                   January 9, 1986
1722 Linden Avenue
Baltimore, Maryland 21217

RE: Kenneth Lynch

Dear Barry:

As a follow-up to our conversation on January 6, 1986, I have reviewed our files and find that we do not have a file on Kenneth Lynch. Apparently I was provided with some of these papers indirectly. I seem to recall that the attorneys from California came to South Carolina and conducted the search for Kenneth Lynch’s papers.

We have not been eager to pursue this due to our understanding that Dr. Lynch was not convinced that asbestos was a cause of cancer. Despite his earlier publications, he remained personally reluctant to state that asbestos was causally related to the formation of cancers until some time in the late 1950’s or early 1960’s. This indecision on his part would be contrary to our best interests in the asbestos litigation and, accordingly, we have discouraged other counsel from exploring this further.

Since we do not have the specific documents you need, perhaps Marcia Hughes could provide them to you from Dick Gerry’s office in San Diego.

With best regards, I am

Very truly yours,

Thomas H. Hart, III

 

Dr. Lynch was a well-known South Carolina pathologist, who, along with Dr. William Smith, published a case report of lung cancer in a patient with asbestosis.  See Kenneth M. Lynch & William A. Smith, “Pulmonary asbestosis III: carcinoma of lung in asbestosilicosis,” 23 Am. J. Cancer 56 (1935).  Plaintiffs’ counsel were eager to over interpret this case report as showing an association, which was beyond the ability of a single, uncontrolled case to do.

The new Rule can be seen to have a few holes in it.  Discovery is permitted into facts or data provided by counsel, and which were considered by the expert witness.  Discovery is also permitted into the identity of assumptions given by the directing counsel, and relied upon by the expert witness.  The letter from Hart to Castleman above, however, illustrates that important insights may result from suggestions, implicit or explicit, not to look at certain facts.

Philadelphia Mass Tort Litigation Acknowledges Its Errant Procedures

December 16th, 2011

Judge John Herron, Administrative Judge of the Trial Division of the Philadelphia Court of Common Pleas recently announced that the Philadelphia courts will suspend their use of consolidation and reverse bifurcation in mass tort actions .  The Court had previously announced that it was studying whether consolidation and reverse bifurcation procedures have adequate procedural safeguards in place “to assure fair and just disposition of actions filed.”  See Notice to the Bar – Mass Tort Program (Dec. 8, 2011).  The Court also indicated that after a period of studying these procedures, the Court may reinstate reverse bifurcation and consolidation if the Court believes that the procedures are implemented fairly.  Reverse bifurcation in pharmaceutical cases will end permanently as of January 1, 2012.

The procedural unfairness of Philadelphia’s handling of so-called mass torts has been described by Joshua D. Wright, a professor of law and economics at George Mason University School of Law, in his study, “Are Plaintiffs Drawn to Philadelphia’s Civil Courts? An Empirical Examination.”  See also Michelle J. White, “Asbestos Litigation: Procedural Innovations and Forum Shopping,” 35 J. Leg. Stud. 365  (June 2006); Michelle J. White, “Understanding the Asbestos Crisis” (2003).

These articles only scratch the surface of what goes on in Philadelphia.  SeePhiladelphia Courts – Structural Bias and Reverse Bifurcation” (Oct. 27, 2011).

The United States Constitution places limits on courts’ abilities to grant separate trials. The Seventh Amendment’s Reexamination Clause provides that:

“no fact tried by a jury, shall be otherwise re-examined in any Court of the United States, than according to the rules of the common law.”

U.S. CONST, amend. VII.  The Supreme Court interpreted the Reexamination Clause to prohibit a grant of a partial new trial in some circumstances:

“Where the practice permits a partial new trial, it may not properly be resorted to unless it clearly appears that the issue to be retried is so distinct and separable from the others that a trial of it alone may be had without injustice.  . . . Here the question of damages on the counterclaim is so interwoven with that of liability that the former cannot be submitted to the jury independently of the latter without confusion and uncertainty, which would amount to a denial of a fair trial.”

Gasoline Prods. Co. v. Champlin Refining Co., 283 U.S. 494, 500 (U.S. 1931). Lower courts have divided over whether the Reexamination Clause is an obstacle to trial bifurcation, with some courts holding that the procedure is prohibited when overlapping issues in the phases of the trial will be reexamined successively in multiple trials.  See W. Russell Taber III, The Reexamination Clause: Exploring Bifurcation in Mass Tort Litigation, 73 Def. Counsel J. 63 (2006).

Philadelphia-style, across-the-board reverse bifurcation certainly has the potential to offend the Reexamination Clause, as well as other constitutional guarantees.  If the bifurcated trials contain issues that are not independent, then the Reexamination Clause would seem offended.  On the other hand, if the trial issues are independent, then the so-called “conjunction paradox” suggests that bifurcation undermines the jury’s evaluation of the burden of proof.  The product rule of probability teaches us that the probability of multiple independent events occurring is the product of the probabilities of each event’s occurring.  If, for instance, the probability of a particular plaintiff’s medical causation claim is 75%, and the plaintiff’s proximate cause claim is 75%, and the plaintiff’s negligence (breach of duty) claim is 75%, the probability of all necessary elements having occurred jointly would be 42.2%.  In a bifurcated trial, plaintiff would win each separate trial easily, but in a “straight-through” trial, plaintiff should fail to carry his burden of proof.  See generally Ward Farnsworth, The Legal Analyst: A Toolkit for Thinking about the Law 273-76 (Chicago 2007).

Apparently, last month, Philadelphia Common Pleas Court Judge Sandra Mazer Moss, who now coordinates the so-called Complex Litigation Center, announced certain asbestos cases – mesothelioma cases in which defendants did not contest diagnosis or asbestos etiology – would be tried in unbifurcated (“straight through”) trials. Michael P. Tremoglie & Jon Campisi, “Reverse Bifurcation Suspended in Philly Mass Torts,” Legal Newsline (Dec. 9, 2011); and The Pennsylvania Record (Dec. 9, 2011).

This policy, like its former incarnations, draws an invidious distinction between those cases in which diagnosis or medical causation is contested and those cases in which diagnosis or medical causation is uncontested.  Previously, Judge Moss would “sever crossclaims,” and force a defendant to proceed to try only its own liability.  The result was that a loss on both medical causation and liability required the judgment defendant to bond an entire judgment, without offset for settling defendants’ shares.  The common thread appears to be pressure defendants to settle, regardless of due process or substantial fairness.

Legalline‘s coverage noted that Judge Moss limited her abandonment of reverse bifurcation in ways that perpetuate the unfairness of Philadelphia procedures:

“This is something the litigants asked for and Judge Moss agreed to. A lot of times the cases would resolve after the damages were seen.

* * * * *

“But since it will be uncontested as to the cause, it will be a ‘straight through’ trial. This way cases will move faster through the court.”

This reasoning makes no sense.  If defendants acquiesce in medical causation, say of a lung cancer claim, they obtain a fair chance to litigate their liability defenses.  If both medical causation and liability are contested, however, defendants are subject to the backwards method of having to risk an adverse medical and damages verdict before the jury hears the defendants’ liability defenses.  Given that very few lung cancer cases, and no extrapulmonary cancers, are caused by asbestos, Philadelphia’s procedures still leave a lot to be desired.

Philadelphia Courts – Structural Bias and Reverse Bifurcation

October 27th, 2011

When I studied federal courts in law school, some of the most interesting cases involving federal diversity and removal jurisdiction were decisions of the Third Circuit, on appeals from the Eastern District of Pennsylvania.  At the time, it did not occur to me that there must be strong incentives to push the boundaries of federal jurisdiction so hard to avoid state court.  A few years later, when I started to try cases in the Philadelphia County Court of Common Pleas, I “got it.”

You probably do not need to have a doctorate in economics to object when someone pisses on you, and calls it rain.  Still, it is comforting to have corroboration from someone with a doctorate.

Joshua D. Wright, a professor of law and economics at George Mason University School of Law, has written up the results of a study, “Are Plaintiffs Drawn to Philadelphia’s Civil Courts? An Empirical Examination,” published by the International Center for Law & Economics.  Professor Wright finds that the Philadelphia civil court system contains significant structural biases, which makes the Philadelphia Court of Common Pleas (PCCP) a magnet for plaintiffs from around the country, and which inflates verdicts and settlements in civil cases.

One such structural bias is the existence of a Complex Litigation Center.  Some of the judges and administrators in charge of the Center have seen their role to be rain makers, to bring litigation business to Philadelphia.  Of course, proper venue and the doctrine of forum non conveniens may tend to get in the way of such an official business plan.

Another structural bias in the Philadelphia courts is the automatic, unthinking use of a procedure called reverse bifurcation.  Typically bifurcation requires plaintiff to establish liability before proceeding to causation and damages, but reverse bifurcation puts causation and damages first.  This bizarre procedure was first urged by Johns-Manville lawyers in asbestos litigation, to avoid the shame and shock of having the jury hear their company’s liability case at the same time that the jury heard the evidence whether plaintiff was injury.  Reverse bifurcation gave them a chance to sanitize the trial on medical causation.  If they lost an up-or-down medical issue, the Johns-Manville lawyers could settle to avoid having the ugly liability evidence shared with the jury.

Johns-Manville soon filed for bankruptcy, but the plaintiffs’ bar learned that reverse bifurcation was a wonderful procedure.  They could get a verdict after three days of trial, and the second phase of the case was virtually untriable by the defense.  Why?  Because the plaintiffs’ lawyers found that they could inject their liability case surreptitiously into the first phase.  Claiming a relevancy to fear and emotional distress, plaintiffs’ counsel asked their clients whether they ever contemplated the horror of living with the increased risks of disease they now supposedly faced, and plaintiffs responded that they had no idea of the risks when they worked at the shipyards, refineries, or other workplaces.  In summation, plaintiffs’ counsel would slip in something like “After the last few days, you, members of the Jury, now know more about asbestos than my client did after 30 years of working in the shipyard.”  Defense objections and motions in limine were studiously ignored.  Who needs to prove a failure to warn, when you can simply assert it?

Egregiously, the reverse bifurcation procedure stuck, even when defendants, unlike Johns-Manville, had potent defenses.  Some Philadelphia judges, in second phase trials, tolerate indignant arguments from plaintiff’s counsel, to the effect that first the (recalcitrant) defendant caused this injury to his client, and now that defendant wants to take away plaintiff’s money, which the jury so thoughtfully, carefully, and justly awarded in the first phase.  Winning a second phase trial, in a case that has been reverse bifurcated, is a bit like cleaning out the Augean stables.

Some judges even went so far, in phase II liability trials as to sever crossclaims of the non-settling defendant.  This procedural maneuver required the defendant to post a bond for the entire judgment, without any offsets, in order to pursue an appeal.  The lack of a final judgment seemed not to disturb anyone other than the victimized defendant.

Not all Philadelphia judges were keen on these inequitable procedures.  I recall trying an asbestos case in front of Judge Levan Gordon, who refused to be bullied by the head of the Complex Litigation Center into reverse bifurcating asbestos trials.  (O’Donnell v. Celotex Corp., PCCP July Term 1982, No. 1619; May 1989)  Judge Gordon had his own strong medicine for defendants:  he tried the cases all issues, with no bifurcation of punitive damages.  Judge Gordon tried my case, which was prosecuted by now Philadelphia Judge Sandy Byrd, straight through.  Because my adversary, Sandy Byrd, insisted on pressing negligence and punitive damages, I was able to try an empty-chair defense against the United States government, which owned and ran the Philadelphia Naval Shipyard, where plaintiff worked.  I was also able to put on a state-of-the-art defense.  And my jury saw what juries rarely see in Philadelphia, the complete story.  They refused to hold my clients responsible for what really was the negligence of the government, even though I had a weak medical defense.

The head of the Complex Litigation Center was furious that Judge Gordon had taken up three weeks of courtroom time.  Her Honor was deaf to explanations that it was plaintiffs’ choice to pursue negligence and punitive damages, which claims opened the door to the sophisticated intermediary and state-of-the-art defenses.  Somehow it was the defendants’ fault for tying up a courtroom, and for derailing the all-important case statistics.

Then, as now, there are some excellent judges in Philadelphia, who are intent to try cases fairly and impartially, with even-handed procedures.  And then there are other judges, who have helped create Philadelphia’s reputation, and the statistics that support Professor Wright’s conclusions.